Memic Innovative Surgery

What Memic Innovative Surgery does

Memic Innovative Surgery, doing business as Momentis Surgical, is a privately held medical device company that develops miniaturized robotic surgical systems. Its flagship product, the Anovo Surgical System, is a two-armed robotic platform featuring humanoid shoulder, elbow, and wrist joints that deliver 360-degree articulation and reach, paired with a 13-pound compact Robotic Control Unit designed for straightforward integration into any operating room. The system is FDA 510(k) cleared for single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures, including total benign hysterectomy (with or without salpingectomy or salpingo-oophorectomy), salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal, and has more recently received clearance to expand into the broader general surgery market.

The company monetizes through direct enterprise sales of the Anovo hardware (including the RCU, instrument arms, and console) to hospitals, ambulatory surgery centers (ASCs), and private practice surgical groups, complemented by professional services and surgeon training delivered through its Momentis University platform. Go-to-market is primarily direct enterprise field sales with a quote-based, multi-year contract pricing model and a "Request a Demo" conversion pathway segmented across investors and healthcare providers. Operationally, Momentis maintains a dual-hub structure with a U.S. commercial headquarters in Fort Lauderdale, Florida, and an R&D and operations presence in Or Yehuda, Israel.

Momentis has raised approximately $127 million in disclosed funding across multiple rounds, most recently a $96 million Series D in April 2021, with backers including Accelmed, Ceros Financial Services, Changer Club, OurCrowd, and Peregrine Ventures. Named reference customers include HCA Northwest Medical Center and HCA Kendall, both within the HCA Healthcare system, providing limited but high-profile commercial validation for the platform.

Name

Memic Innovative Surgery

Legal name

Momentis Innovative Surgery

Website

https://memicmed.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Memic Innovative Surgery (dba Momentis Surgical) develops the Anovo Surgical System, a miniaturized two-armed robotic platform with FDA 510(k) clearance for transvaginal benign procedures and general surgery, sold to hospitals, ASCs, and private practice surgeons.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF), Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE)

Keywords

• Robotic surgical systems
• Surgical robotics
• Minimally invasive surgery
• Medical devices
• Surgical automation

Headquarters

HQ city

Or Yehuda

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Anovo Surgical System Hardware Sales: Sale of the Anovo Surgical System including the Robotic Control Unit (RCU), instrument arms, and console components to hospitals, ASCs, and surgical centers.
2. Professional Services and Training: Training services for surgeons through Momentis University platform, implementation support, and ongoing customer success programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Memic Innovative Surgery (operating as Momentis Surgical) develops and manufactures miniaturized robotic-assisted surgical platforms, principally the Anovo Surgical System, designed to enable surgeons to perform transvaginal and other minimally invasive procedures through small ports. The company sells the hardware system along with associated instruments and consumables to hospitals, ambulatory surgery centers (ASCs), and surgical practices.

Product overview

Memic Innovative Surgery (operating as Momentis Surgical) offers the Anovo Surgical System as its primary product — a miniaturized robotic surgical platform designed for minimally invasive procedures. The system enables surgeons to perform precise movements through a 2-armed robotic configuration with humanoid articulation. Originally focused on transvaginal benign surgical procedures (hysterectomy, salpingectomy, oophorectomy, adnexectomy, ovarian cyst removal), the company has expanded into general surgery following FDA 510(k) clearance. The portfolio also includes Momentis University, a dedicated training platform for surgeon certification on the system.

Differentiator

Problem solved

Functional benefit

Brands

• Anovo Surgical System: Robotic surgical system featuring miniaturized humanoid arms with 360-degree articulation, designed for single-site transvaginal minimally invasive procedures including benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal.

Products and services

• Anovo Surgical System A miniaturized, single-port robotic-assisted surgical platform with multiple articulating instruments, intended for gynecologic and other minimally invasive procedures such as benign hysterectomy via a transvaginal approach. The system is sold to hospitals, ambulatory surgery centers, and private-practice surgical groups in the United States.
• Anovo Instruments and Consumables Disposable and reusable articulating instruments, graspers, and accessories used with the Anovo Surgical System during minimally invasive and transvaginal surgical procedures. Sold to existing Anovo customers to support ongoing surgical volume.
• Surgeon and Staff Training Services Clinical training, proctoring, and onboarding programs that prepare surgeons, OR staff, and clinical teams to safely adopt the Anovo Surgical System. Delivered to hospitals, ambulatory surgery centers, and surgical practices purchasing or evaluating the system.

Quantifiable outcome

• 13-pound robotic control unit enabling portable OR integration
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Emerging players

• Vicarious Surgical: Early-stage surgical robotics company developing a single-port robotic platform, closely comparable to Momentis's miniaturization and single-site positioning.
• Moon Surgical: Early-stage surgical robotics company focused on compact, surgeon-controlled robotic assistance in the OR, addressing similar cost and footprint pain points as Momentis.
• Distalmotion: European surgical robotics company developing the Dexter robot, with a similar emphasis on portability, cost, and OR integration versus legacy systems.
• Asensus Surgical: Surgical robotics and digital laparoscopy company developing the Senhance platform, competing in the same soft-tissue minimally invasive space as Momentis.
• CMR Surgical: Developer of the Versius modular surgical robot, a compact alternative to legacy systems targeting hospitals and ASCs — directly comparable positioning to Anovo.
• Titan Medical: Single-port surgical robotics developer pursuing a similar minimally invasive positioning to Momentis, historically through the Enos platform.

Broad incumbents

• Stryker: Major medtech incumbent with the Mako orthopedic robotics platform; relevant broad incumbent peer given shared capital equipment sales motion into hospitals.
• Medtronic: Diversified medtech major that has launched the Hugo surgical robotics platform, directly competing in soft-tissue robotics while leveraging its hospital relationships and capital scale.
• Johnson & Johnson (Ethicon / Ottava): Healthcare conglomerate developing the Ottava surgical robotics platform through Ethicon; competes in soft-tissue robotics with broad portfolio leverage and large capital base.

Direct peers

• Intuitive Surgical: The dominant soft-tissue surgical robotics company (da Vinci platform) and the primary incumbent Momentis must displace or sit alongside in hospital robotics budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds7 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Memic Innovative Surgery